UBE2Q1 and colorectal cancer: In this study, it was hypothesized that LINC00525 regulated the expression of UBE2Q1 is activated by miR-338-3p via the bridging effect, whereas UBE2Q1 activated HIF-1 via stabilizing-catenin, ultimately promoting hypoxia-enhanced glycolysis in colorectal cancer.